证券日报网讯西力科技11月24日在互动平台回答投资者提问时表示，截至三季度末，公司股东人数5858 户。 ...

Group 1 - The core viewpoint of the news is that Xili Technology experienced a decline in stock price and trading volume, with significant changes in financing and shareholder metrics [1][2]. - On November 21, Xili Technology's stock fell by 4.87%, with a trading volume of 35.48 million yuan. The net financing buy was -599,200 yuan, indicating a higher level of financing balance compared to the past year [1]. - The financing balance of Xili Technology as of November 21 is 48.54 million yuan, accounting for 2.23% of the circulating market value, which is above the 60th percentile of the past year [1]. Group 2 - As of September 30, the number of shareholders of Xili Technology decreased by 7.37% to 5,858, while the average circulating shares per person increased by 7.95% to 30,621 shares [2]. - For the period from January to September 2025, Xili Technology reported a revenue of 403 million yuan, a year-on-year decrease of 14.19%, and a net profit attributable to the parent company of 66.34 million yuan, down 11.48% year-on-year [2]. - Xili Technology has distributed a total of 196 million yuan in dividends since its A-share listing, with 128 million yuan distributed over the past three years [3].

Core Viewpoint - The company has not exported products to the European Union in the past two years [2] Company Summary - The company responded to investor inquiries on November 14, indicating a lack of exports to the EU region [2]

Group 1 - Company plans to raise no more than 3.6 billion yuan through a private placement to fund seven projects, including a 500,000 kW green power project in Inner Mongolia [1] - Company has received acceptance for a clinical trial application for its self-developed drug for metastatic pancreatic ductal adenocarcinoma [1] - Company intends to establish a joint venture to implement a high-quality gallium arsenide chip construction project with a total investment of 272 million yuan [2] Group 2 - Company reported a revenue of 142 million yuan from pig sales in October, with a total sales volume of 162,800 pigs [3] - Company signed an annual procurement contract to supply 870,000 tons of electrolyte products from 2026 to 2028 [5] - Company plans to reduce its shareholding by up to 3% through various trading methods [7] Group 3 - Company intends to purchase 100 hydrogen fuel cell vehicles for a total price of 78.32 million yuan [9] - Company plans to acquire a 51% stake in a semiconductor equipment company for 510 million yuan [10] - Company has regained eligibility to participate in military procurement activities after being removed from the banned list [12] Group 4 - Company plans to establish a joint venture with state-owned funds for rural development with a total registered capital of 2.87 billion yuan [14] - Company reported a revenue of 1.918 billion yuan from pig sales in October, with a significant year-on-year increase [16][17] - Company plans to distribute a cash dividend of 0.01 yuan per share, totaling 7.9801 million yuan [18] Group 5 - Company has submitted an application for H-share listing on the Hong Kong Stock Exchange [19] - Company received approval for its convertible bond issuance application [20] - Company plans to establish a wholly-owned subsidiary with an investment of 70 million yuan focused on innovative medical research [22] Group 6 - Company reported a 33.87% year-on-year increase in sales volume for October [26] - Company has received a product designation from a leading new energy vehicle brand, with an expected total revenue of approximately 470 million yuan [28] - Company has initiated a key Phase III clinical trial for an innovative eye drop treatment for moderate to severe dry eye syndrome [30] Group 7 - Company reported a total automobile sales volume of 170,700 units in October, a year-on-year decrease of 8.1% [30] - Company plans to invest 16 million USD in establishing a production base in Vietnam [33] - Company has received a warning letter from the regulatory authority due to a breach of commitment by its controlling shareholder [52]

证券代码：688616 证券简称：西力科技 公告编号：2025-037 杭州西力智能科技股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 会议召开地点：上海证券交易所上证路演中心（网址： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 11 月 10 日（星期一）至 11 月 14 日 （星期 五）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或 通过公司邮箱 zqb@cnxili.com 进行提问。公司将在说明会上对投资 者普遍关注的问题进行回答。 杭州西力智能科技股份有限公司（以下简称"公司"）已于 2025 年 10 月 28 日发布公司 2025 年第三季度报告，为便于广大投资者更 全面深入地了解公司 2025 年第三季度经营成果、财务状况，公司计 划于 2025 年 11 月 17 日（星期一）14:00-15:00 举行 2025 年第三季 度业绩说明会，就投资者 ...

证券代码：688616 证券简称：西力科技 公告编号：2025-036 杭州西力智能科技股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 股东及一致行动人持股的基本情况 1、截至本公告披露日，杭州西力智能科技股份有限公司（以下简称"公司"） 股东德清西力科技信息咨询合伙企业（有限合伙）（以下简称"德清西力"）系公 司员工持股平台，持有公司股份 7,552,000 股，占公司总股本 4.21%，为公司控 股股东、实际控制人、董事宋毅然先生一致行动人。德清西力持有的公司股份为 公司首次公开发行前取得的股份以及公司资本公积转增股本所得，已于 2024 年 3 月 18 日解除限售并上市流通。 2、公司股东德清聚源科技信息咨询合伙企业（有限合伙）（以下简称"德清 聚源"）系公司员工持股平台，持有公司股份 5,298,000 股，占公司总股本 2.95%， 为公司大股东、董事周小蕾女士一致行动人。德清聚源持有的公司股份为公司首 次公开发行前取得的股份以及公司资本公积转增股 ...

Corporate Announcements - China Aluminum announced the election of He Wenjian as chairman and the appointment of Zhang Ruizhong as general manager, with Zhang holding 147,100 shares of A-shares [4] - Jiangbolong reported that its self-developed main control chip deployment exceeded 100 million units by the end of Q3, with ongoing rapid growth [5] - Asia-Pacific Pharmaceutical received a notice of disapproval for the consistency evaluation application of Diltiazem Hydrochloride Tablets, which will not significantly impact current performance [6] - Fuxiang Pharmaceutical successfully passed the FDA's cGMP inspection, marking the third successful inspection, enhancing its qualification for international market supply [7] - Biaobang Co. terminated its control change planning due to failure to reach consensus on core terms, leading to stock resumption [8] - Jingjin Equipment announced the release of its actual controller and chairman from detention, allowing normal operations [9] - Sand Membrane reported that part of its fundraising account was frozen, amounting to 11.74 million yuan, related to a contract dispute [10] - Renfu Pharmaceutical's subsidiary received approval for clinical trials of HWH217 tablets for treating pulmonary arterial hypertension [12] - Wanye Enterprises will change its stock name to "Xian Dao Ji Dian" effective November 12 [13] - Huahai Pharmaceutical's subsidiary passed the FDA inspection, ensuring compliance with international standards [14] Performance Metrics - Daqin Railway reported a cargo transport volume of 32.51 million tons in October, a decrease of 4.7% year-on-year [19] - Jingji Agriculture announced sales of 233,300 pigs in October, generating revenue of 317 million yuan [20] - Baiyun Airport reported a passenger throughput of 7.64 million in October, a year-on-year increase of 12.04% [21] - Dongfeng Motor's total vehicle production decreased by 23.4% year-on-year in October, with significant declines in commercial vehicle categories [22] - Hongyang Real Estate reported a contract sales amount of 202 million yuan in October [23][24] Shareholding Changes - Xintonglian announced that a shareholder plans to reduce its stake by up to 3% [25] - Tonghua Dongbao conducted its first share buyback, acquiring 0.01% of its shares for 1.29 million yuan [26] - Guoci Materials plans to repurchase shares worth 100 million to 200 million yuan at a price not exceeding 30 yuan per share [27] - Xili Technology announced multiple shareholders plan to reduce their stakes [28] Major Contracts - Dayu Water announced a pre-bid win for a 310 million yuan water conservancy project in Hainan [29] - Zhongjian Technology signed a significant sales contract worth 563 million yuan [30] - Longjian Co. won a bid for a 441 million yuan project for road construction in Heilongjiang [31] - Chongqing Construction's subsidiary won a bid for a 781 million yuan project in Chongqing [32]

Core Insights - On November 6, 23 A-share listed companies disclosed shareholding reductions, while Guocera Materials announced a share repurchase plan of 100 million to 200 million yuan [1][2]. Summary of Share Repurchase and Reduction Share Repurchase - Guocera Materials plans to repurchase company shares worth between 100 million and 200 million yuan [2]. Share Reductions - Wenke Co., Ltd. plans to reduce its holdings by no more than 0.55% of the company's shares [2]. - Zhenhua Co., Ltd. saw three directors collectively reduce their holdings by 64,000 shares during a period of abnormal stock trading [2]. - Hubei Investment Company plans to reduce its holdings in Lijing Mico by no more than 0.77% [2]. - Executive Xu Jinzhu of Zhou Dashing plans to reduce his holdings by no more than 0.0117% [2]. - Panxin Investment intends to reduce its holdings in Dali Cap by no more than 4.5% [2]. - Director and executive Zou Peng of Wanli Stone plans to reduce his holdings by no more than 1.63% [2]. - Three executives of Gaomeng New Materials plan to collectively reduce their holdings by no more than 0.061% [2]. - Directors and executives of Feiliwa plan to collectively reduce their holdings by no more than 0.1187% [2]. - Specific shareholders and Huang Jian plan to collectively reduce their holdings in Bangyin Co. by no more than 2.82% [2]. - Shareholders and Feng Investment plan to reduce their holdings in New Light Pharmaceutical by no more than 3% [2]. - Vice General Manager Cui Rong of Online and Offline plans to reduce his holdings by no more than 0.03% [2]. - Shareholders Yao Xiaoqing and executives of Hongri Pharmaceutical plan to collectively reduce their holdings by no more than 1.576% [2]. - Beijing Yindi Investment and its concerted parties plan to collectively reduce their holdings in Mengguli by no more than 3% [2]. - Shareholders of Maituo Co. plan to reduce their holdings by no more than 0.86% [2]. - Wanze Investment plans to reduce its holdings in Huawei Technology by no more than 1.92% [2]. - Director Bi Songling of Shandong Heda plans to reduce his holdings by no more than 0.1017% [2]. - Shareholder Zhang Li of Chongde Technology cumulatively reduced 531,900 shares from October 24 to November 6 [2]. - Ruize Investment plans to reduce its holdings in Weiao Co. by no more than 3% [2]. - Jining Bochuang plans to reduce its holdings in New Fengguang by no more than 0.1978%, while Xu Lin plans to reduce by no more than 0.5354% [2]. - Shareholder Yili Group reduced its holdings in Sun Cable by 1.20% of the total share capital [2]. - A concerted party of a controlling shareholder of Liande Co. reduced 1,952,800 shares on November 5 [2]. - Shareholders plan to collectively reduce their holdings in Xili Technology by no more than 2.08% [2]. - Shareholder Bi Fang Investment plans to reduce its holdings in New Tonglian by no more than 3% [2].

Corporate Governance - China Aluminum announced the election of He Wenjian as chairman and the appointment of Zhang Ruizhong as general manager, effective immediately [3] - Jiang Guiting, the actual controller and chairman of Jingjin Equipment, has had his detention lifted, allowing him to resume his duties [8] - Biao Bang Co. has terminated its plans for a change in control, with stock resuming trading [7] Industry Developments - Jiangbolong reported that its self-developed main control chip deployment has exceeded 100 million units, with rapid growth expected [4] - Asia Pacific Pharmaceutical received a notice of disapproval for its consistency evaluation application for a drug, which will not significantly impact its current performance [5] - Fuxiang Pharmaceutical successfully passed a cGMP inspection by the FDA, marking its third successful inspection [6] - Huahai Pharmaceutical's subsidiary passed an FDA inspection, enhancing its international market capabilities [13] Financial Performance - Daqin Railway reported a cargo transport volume of 32.51 million tons in October 2025, a year-on-year decrease of 4.7% [18] - Jingji Zhino achieved sales revenue of 317 million yuan from selling 233,300 pigs in October 2025 [19] - Baiyun Airport reported a passenger throughput of 7.64 million in October 2025, a year-on-year increase of 12.04% [20] - Dongfeng Motor's total vehicle production in October 2025 was 6,536 units, a year-on-year decrease of 23.40% [21] - Hongyang Real Estate reported a contract sales amount of 202 million yuan in October 2025 [22] Shareholder Actions - Xintonglian announced that a shareholder plans to reduce its stake by up to 3% [24] - Tonghua Dongbao conducted its first share buyback, acquiring 143,500 shares for 1.29 million yuan [25] - Guoci Materials plans to repurchase shares worth 100 million to 200 million yuan at a price not exceeding 30 yuan per share [26] Project Wins - Dayu Water-saving announced a pre-bid win for a 310 million yuan water conservancy project in Hainan [28] - Zhongjian Technology signed a significant sales contract worth 563 million yuan [29] - Longjian Co. won a project bid worth 441 million yuan for road construction in Heilongjiang [30] - Chongqing Construction's subsidiary won a project bid worth 781 million yuan for a residential project in Chongqing [31]

Core Viewpoint - Xili Technology (688616.SH) announced that major shareholders plan to reduce their holdings in the company through various trading methods within the next three months, which may impact the stock's performance [1] Shareholder Reduction Plans - Shareholder Deqing Xili plans to reduce up to 1.194 million shares, representing no more than 0.67% of the total share capital, within three months after 15 trading days from the announcement [1] - Shareholder Deqing Juyuan intends to reduce up to 1.027 million shares, accounting for no more than 0.57% of the total share capital, within the same timeframe [1] - Individual shareholder Yu Jianping plans to reduce up to 1.5 million shares, which is no more than 0.84% of the total share capital, also within three months after 15 trading days from the announcement [1] Conditions of the Reduction - The reduction plans will be adjusted accordingly if there are changes in the number of shares due to stock dividends or capital reserve transfers during the implementation period [1] - The company's controlling shareholder and actual controller have committed not to participate in this reduction plan or share in the proceeds from the share reduction during the implementation period [1]